BDBM100854 US8507533, 176

SMILES: CCCC(Nc1ccc(nc1)-n1cc(cn1)C1CC1)c1ccc(cc1)C(=O)NCCC(O)=O

InChI Key: InChIKey=IFNFTVDAMAIFRB-UHFFFAOYSA-N

Data: 1 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 100854   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Pro-glucagon (Homo sapiens (Human))	BDBM100854 (US8507533, 176) Show SMILES CCCC(Nc1ccc(nc1)-n1cc(cn1)C1CC1)c1ccc(cc1)C(=O)NCCC(O)=O Show InChI InChI=1S/C25H29N5O3/c1-2-3-22(18-6-8-19(9-7-18)25(33)26-13-12-24(31)32)29-21-10-11-23(27-15-21)30-16-20(14-28-30)17-4-5-17/h6-11,14-17,22,29H,2-5,12-13H2,1H3,(H,26,33)(H,31,32)	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	101	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.				US Patent US8507533 (2013) BindingDB Entry DOI: 10.7270/Q23R0RGH
					More data for this Ligand-Target Pair